What is Aprea Therapeutics Inc (APRE) stock price today?

Aprea Therapeutics Inc (APRE) currently trades at $0.82 per share. The stock has a market capitalization of $9.81M and a P/E ratio of —x.

Is APRE stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Aprea Therapeutics Inc has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Aprea Therapeutics Inc's revenue and earnings?

Aprea Therapeutics Inc has trailing twelve-month (TTM) revenue of $285760.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.93.

APRE

Aprea Therapeutics Inc

NASDAQ: APRE · HEALTHCARE · BIOTECHNOLOGY

$0.82

-2.14% today

Updated 2026-04-29

Market cap

$9.81M

P/E ratio

—

P/S ratio

34.34x

EPS (TTM)

$-1.93

Dividend yield

—

52W range

$1 – $2

Volume

0.5M

Market cap

$9.81M

P/E ratio

—

P/S ratio

34.34x

EPS (TTM)

$-1.93

Dividend yield

—

52W range

$1 – $2

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$4.40

+437.24%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.07M

- Revenue declining -98.40% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$583231.00	$1.50M	$285759.00	$285760.00
Net income	$-112.66M	$-14.29M	$-12.96M	$-12.60M	$-2.46M
EPS	—	—	—	—	$-1.93
Free cash flow	$-25.01M	$-12.27M	$-13.57M	$-12.89M	$-3.07M
Profit margin	—	-2,449.59%	-862.43%	-4,409.16%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
APRE	$9.81M	24	3.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Aprea Therapeutics Inc trades at $0.82. Our Smart Value Score of 24/100 indicates the stock is weak. TTM revenue stands at $285760.00.

Frequently asked questions

What is Aprea Therapeutics Inc's stock price?

Aprea Therapeutics Inc (APRE) trades at $0.82.

Is Aprea Therapeutics Inc overvalued?

Smart Value Score 24/100 (Grade F, Strong Sell).

What is the price target of Aprea Therapeutics Inc (APRE)?

The analyst target price is $4.40, representing +437.2% upside from the current price of $0.82.

What is Aprea Therapeutics Inc's revenue?

TTM revenue is $285760.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio34.34x

ROE-74.60%

Beta1.57

50D MA$0.81

200D MA$1.17

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

APRE vs LLY →APRE vs JNJ →APRE vs ABBV →Stock screener →